Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.07K Buy
30,205
+29,207
+2,927% +$6.71K ﹤0.01% 8626
2025
Q4
$265 Buy
998
+136
+16% +$62 ﹤0.01% 10070
2025
Q3
$603 Sell
862
-15,629
-95% -$17.4K ﹤0.01% 9606
2025
Q2
$28.7K Sell
16,491
-9,564
-37% -$18.1K ﹤0.01% 8198
2025
Q1
$52.6K Buy
26,055
+20,240
+348% +$46K ﹤0.01% 7551
2024
Q4
$16.5K Buy
+5,815
New +$19K ﹤0.01% 8002
2024
Q1
Sell
-8
Closed -$1.44K 9292
2023
Q4
$1.44K Buy
8
+7
+700% +$1.95K ﹤0.01% 8300
2023
Q3
$218 Buy
+1
New +$554 ﹤0.01% 8682

Other funds holding AZTR

UBS Group's AZTR Position: Q1 2026 in Review

UBS Group increased its Azitra (AZTR) stake by 2,927% in Q1 2026, buying an estimated $6.71K and bringing the position to 30,205 shares worth $7.07K. The position accounts for ﹤0.01% of the portfolio, ranked #8626.

UBS Group first reported a position in AZTR in Q3 2023 and has held it in 8 quarters since. The position peaked at $52.6K in Q1 2025. 7 funds tracked by Wall St. Rank hold AZTR as of Q1 2026.

  • UBS Group held 30,205 shares of Azitra worth $7.07K as of Q1 2026.
  • UBS Group bought 29,207 Azitra shares in Q1 2026, an estimated $6.71K.
  • Azitra made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8626 holding.
  • UBS Group first reported a position in Azitra in Q3 2023 and has held it in 8 quarters since.
  • UBS Group's Azitra position peaked at $52.6K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Azitra as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.